RecruitingNCT06958016
Role of Tryptase Levels in Patients With Stable Coronary Artery Disease.
Investigation of the Role and Prognostic Value of Tryptase in Patients With Stable Coronary Artery Disease
Sponsor
University of Thessaly
Enrollment
200 participants
Start Date
Jan 12, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
The aim of this study is to measure the levels of serum tryptase and correlate them with the severity of coronary artery disease in study population. In addition, it will evaluate the usability of tryptase levels as a prognostic biomarker for future cardiovascular events.
Eligibility
Min Age: 18 YearsMax Age: 85 Years
Inclusion Criteria3
- Male and female subjects aged 18 - 85 years old.
- Clinical symptoms of angina which are classified based on the Canadian Cardiovascular Score (CCS score)
- Positive SPECT scan for myocardial ischemia
Exclusion Criteria11
- Acute Coronary Syndrome 4 weeks before the coronary catheterization
- Percutaneous Coronary Angioplasty
- Coronary Artery Bypass Graft
- Active symptoms of allergy (asthma, urticaria)
- Mastocytosis
- Hypereosinophilia
- Autoimmune disease
- Cancer
- Kidney failure
- Myelodysplastic Syndrome
- Denial of signing informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06958016
Related Trials
Orbital Atherectomy vs Intravascular Lithotripsy for the Treatment of Calcified Coronary Nodules (ORBIT-SHOCK).
NCT067366656 locations
Effect of ZaStaprazan on Platelet Reactivity of Clopidogrel After PercuTaneous CoronAry InteRvention
NCT074718671 location
Artificial Intelligence-Driven Medipixel Fractional Flow Reserve Versus Invasive Fractional Flow Reserve-Guided PCI Trial (AIM-FFR Trial)
NCT0732969923 locations
Computational mOdelliNg of myoCardial pERfusion to Improve ouTcome Prediction Based on cOronary Artery Stenosis and Atherosclerotic Plaque Burden Assessment by Computed Tomography
NCT063374611 location
Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial)
NCT0719514918 locations